Ron Wyden

I hope this committee reverts to tradition on taxes.

Lawmakers ought to keep their promises when it comes to tax cuts before rushing ahead with a second bill.

The new tax law has turned out to be an awfully expensive dud.

Millions of families are looking around and wondering when they are going to see those wage hikes that they were promised.

Once again, the fortunate few are reaping the benefits.

When you are talking about legislation that is going to cost nearly $2 trillion when it is all said and done, it is not easy to fail at your stated goal so spectacularly.

The reality is the new law has done little for folks who work so hard to earn a wage and cover the bills.

Colleagues, in my view, lawmakers ought to think twice about big, new promises if they have not delivered on the ones they have already made.

I think our country will regret it.

The process used for tax reform was light years away from what we did for CHIP.

I think we need a game plan from you.

There are a lot of folks in the West who never thought that this day was going to come.

We have gotten it done and our job now is to build on that accomplishment.

I appreciate your attention to this important issue and your consideration of my requests.

Congress would be derelict in its responsibilities if it pretends there is no profit motive or corporate scheming behind this addiction crisis.

It is long past time to get the opioid executives before this committee, have them raise their right hands, and hold them accountable for their role in creating a public health calamity that is killing tens of thousands of Americans each…

In 2017, I wrote again to HHS regarding a workshop hosted by the Food and Drug Administration on safe opioid prescribing when it was revealed that some participants shared financial ties with Purdue Pharma and other prominent manufacturers.

To me, opioid manufacturers, through twisted research, deceptive marketing, and bought and paid for patient advocacy groups had a significant role in fueling the crisis.

We are going to get a bipartisan bill from the Finance Committee, because Chairman Hatch and I have been talking about this for some time.

We are going to do that under the leadership of the chairman. This is going to be tackled in the same kind of way that we pursued the CHIP bill for 10 years, the historic Family First bill, the potentially transformative Medicare…

I think that the opioid manufacturers, through twisted research, deceptive marketing, and bought-and-paid-for advocacy groups, had a significant role to play in creating and fueling the crisis.

When we wrap up, we are going to ask that there be a response to questions for the record...

Thank you, Senator Casey.

To me, opioid manufacturers--through twisted research, deceptive marketing, and bought and paid-for patient advocacy groups--had a significant role in fueling the crisis.

We are committed here on this Committee--you heard the chairman and I talk about it--to being bipartisan.